Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-18, Stock:JNJ, The news for the past five days is as follows:
2021-02-10: NEWS1: Ortho Clinical Diagnostics: What You Need to Know.NEWS2: S.Africa aims to immunise 500,000 health workers in J&J study, scientist says.NEWS3: WHO team member hits back at criticism of Wuhan mission as global COVID tally tops 107 million.NEWS4: Annual Covid-19 Boosters May Be Needed, J&J CEO Says.NEWS5: Novavax Keeps Hitting New Records After Seeking Covid Vaccine OK; Is It A Buy?.NEWS6: 3 Best Biotech Stocks to Buy Now.NEWS7: UPDATE 6-S.Africa may sell AstraZeneca shots as it switches to J&J vaccine to fight variant.
2021-02-11: NEWS1: Biden says U.S. is ahead of pace, will have vaccines for 300 million Americans by end of July.NEWS2: UPDATE 2-S.Africa to start vaccinating millions against local COVID-19 variant -Ramaphosa.NEWS3: U.K. scientist warns new COVID variant will ‘sweep the world,’ as California confirms two cases of South African strain.NEWS4: The Horizons Psychedelic Stock Index ETF, As Told By Its Fund Manager.NEWS5: AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally.NEWS6: Johnson & Johnson's Coronavirus Vaccine Data Isn't as Bad as It First Appears.
2021-02-12: NEWS1: Impact of Covid-19 virus variants on vaccine distribution.NEWS2: Eli Lilly Keeps Piling Up Share Price Gains.NEWS3: Public Health Professor on COVID-19: ‘The big question though is how many people will be willing to get vaccinated’.NEWS4: Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?.NEWS5: U.S. COVID vaccine program enters new phase as feds deliver jabs directly to drug store chains.NEWS6: What Is Vaxart Worth Now?.NEWS7: Can COVID Vaccine Makers Benefit From the Biden Administration?.NEWS8: Pharma Stock Roundup: AZN's Q4 Earnings, FDA Approval for LLY & SNY's Drugs.NEWS9: The U.S. is getting plenty of COVID-19 vaccines, but you still won’t have a normal summer.NEWS10: The U.S. Will Be Swimming in Covid-19 Vaccines by Midsummer.NEWS11: How Long Until We Reach Herd Immunity? Expert Timelines Vary.NEWS12: Could the U.S. Buying More COVID Vaccines Hurt Johnson & Johnson and Novavax?.NEWS13: Upstart Entrants and Booster Shots: How the Pandemic Is Changing the Vaccine Industry..NEWS14: Vaccines, Energy Top South African President’s Priority List.
2021-02-16: NEWS1: Relaxing mitigation measures will 'recapitulate what we’ve already been seeing with further sickness': Doctor.NEWS2: Storm, power outages impact vaccine distribution.NEWS3: South Africa restarts its vaccine drive as the first country to use the Johnson & Johnson shot.NEWS4: Is AstraZeneca Stock A Buy After U.K., Europe Authorize Covid Vaccine?.NEWS5: South Africa plans to share AstraZeneca vaccine, first J&J shots expected.NEWS6: Why the three biggest vaccine makers failed on Covid-19.
2021-02-17: NEWS1: Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected.NEWS2: Coronavirus update: Biden administration increases vaccine doses to states; UK approves first human challenge trial.NEWS3: Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears.NEWS4: COVID-19 cases are dropping like a rock: Morning Brief.NEWS5: Johnson & Johnson has only a few million COVID vaccine doses in stock as likely launch nears.NEWS6: 3 Surefire Stocks to Buy If the Market Crashes.NEWS7: Novavax Trips Despite Covid Vaccine License Deal; Is NVAX Stock A Buy?.NEWS8: Like Dividends? I Bet You'll Love These 3 Stocks.NEWS9: UPDATE 4-'I feel blessed', says doctor as South Africa launches vaccination drive.NEWS10: Here's Why We're Wary Of Buying Johnson & Johnson's (NYSE:JNJ) For Its Upcoming Dividend.

Answer: Rise